# Ligand (LGND) — Analyst Forecast

LGND · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lgnd/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 11 | 0 | 0 | 11 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $326.00 | $350.17 | $397.00 | 6 |

Last price $293.28 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 25, 2026 | Barclays | Initiated Coverage | Overweight | $345.00 |
| Sep 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $358.00 |
| Sep 23, 2026 | Citigroup | Maintained | Buy | $397.00 |
| Aug 14, 2026 | Leerink Partners | Initiated Coverage | Outperform | $330.00 |
| Aug 7, 2026 | RBC Capital | Maintained | Outperform | $345.00 |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | $358.00 |
| Aug 3, 2026 | Oppenheimer | Maintained | Outperform | $326.00 |
| Jul 21, 2026 | Citigroup | Maintained | Buy | $387.00 |
| Jul 15, 2026 | RBC Capital | Maintained | Outperform | $340.00 |
| Jul 9, 2026 | B of A Securities | Maintained | Buy | $388.00 |
| Jul 8, 2026 | Stifel | Maintained | Buy | $332.00 |
| May 8, 2026 | RBC Capital | Maintained | Outperform | $262.00 |
| Apr 30, 2026 | HC Wainwright & Co. | Maintained | Buy | $289.00 |
| Apr 28, 2026 | RBC Capital | Maintained | Outperform | $252.00 |
| Apr 15, 2026 | Citigroup | Maintained | Buy | $282.00 |
| Apr 14, 2026 | HC Wainwright & Co. | Maintained | Buy | $243.00 |
| Mar 24, 2026 | Citigroup | Maintained | Buy | $276.00 |
| Mar 11, 2026 | B of A Securities | Initiated Coverage | Buy | $244.00 |
| Feb 27, 2026 | Oppenheimer | Maintained | Outperform | $277.00 |
| Feb 24, 2026 | HC Wainwright & Co. | Maintained | Buy | $239.00 |

## Frequently Asked Questions

### What is the price target for LGND stock?

The average 12-month analyst price target for Ligand (LGND) is $350.17, with a high estimate of $397.00 and a low of $326.00, across 6 analysts.

### Is LGND a buy, sell, or hold?

Analysts covering Ligand currently average a Buy rating: 11 buy, 0 hold and 0 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for LGND?

The average price target of $350.17 implies 19.40% upside from the last price of $293.28.

### What is the latest analyst rating on LGND?

On Sep 25, 2026, Barclays initiated coverage of Ligand at Overweight with a price target of $345.00.

## Similar Stocks

- [ANIP](https://www.lighthorse.io/tickers/anip) — ANI Pharmaceuticals, Inc. - Common Stock
- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).